Jun Luo is an Assistant Professor of Urology at the Johns Hopkins School of Medicine. His research focuses on prostate cancer biology, detection, and treatment. He received his B.S. in Zoology from Nanjing University in 1990 and completed a Ph.D. in Anatomy and Cell Biology at the University of Iowa in 1999. He then completed a postdoctoral fellowship in oncogenomics at Johns Hopkins University in 2002 and joined the Johns Hopkins staff that same year. He holds two patents for discoveries that assist in the detection of prostate cancer. He has published extensively and has won numerous awards for his scholarship and research. He is a member of the American Association for Cancer Research, the American Urological Association, the American Society of Clinical Oncology, and the Society for Basic Urologic Research.
Channing J. Paller, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, where she specializes in the development of new prostate cancer therapeutics. She serves as director of prostate cancer clinical research at Hopkins. She earned her MD at Harvard Medical School and completed her medical residency at the Johns Hopkins Hospital, where she was a member of the Osler Housestaff Program, and her Fellowship in Medical Oncology at the Johns Hopkins Kimmel Cancer Center. She is focused on translational research and clinical trials of developmental therapeutics in prostate and other solid tumors. Her research focus is on the evaluation of new therapies, such as targeted therapies.
